Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer-Reference-Cited by-同舟云学术

Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer

Published:2016-10-03 Issue:1 Volume:140 Page:103-108
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zhang Le-Le¹,Kan Mengyuan¹,Zhang Man-Man¹,Yu Sha-Sha²,Xie Hui-Jun²,Gu Zhao-Hui²,Wang Hai-Ning²,Zhao Shuang-Xia¹,Zhou Guang-Biao³,Song Huai-Dong¹²,Zheng Cui-Xia¹

Affiliation:

1. Department of Respiration; Center Lab in Research Center for Clinical Medicine, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine; Shanghai China

2. State Key Laboratory of Medical Genomics; Shanghai Jiaotong University School of Medicine; Shanghai China

3. State Key Laboratory of Biomembrane and Membrane Biotechnology; Institute of Zoology, Chinese Academy of Sciences, University of Chinese Academy of Sciences; Beijing China

Funder

National Natural Science Foundation of China

National Basic Research Program of China (973)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Cancer statistics, 2015;Siegel;Cancer J Clin,2015

2. Tumour heterogeneity in the clinic;Bedard;Nature,2013

3. Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib;Taniguchi;Cancer Sci,2008

4. Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer;Bai;PLoS One,2013

5. The clonal evolution of tumor cell populations;Nowell;Science,1976

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds;Cell Communication and Signaling;2024-07-26

2. Identification of Novel Stemness-based Subtypes and Construction of a Prognostic Risk Model for Patients with Lung Squamous Cell Carcinoma;Current Stem Cell Research & Therapy;2024-04

3. My battle with cancer. Part 1;Oncoscience;2024-01-03

4. Early Evolution in Cancer: A Mathematical Support for Pathological and Genomic Evidence in Clear Cell Renal Cell Carcinoma;Cancers;2023-12-18

5. In‐frame deletion of SMC5 related with the phenotype of primordial dwarfism, chromosomal instability and insulin resistance;Clinical and Translational Medicine;2023-01